Rofecoxib for osteoarthritis and pain

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 1999年 / 41卷 / 1056期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：59 / 61
页数：3
相关论文
共 50 条
  • [1] Rofecoxib for osteoarthritis
    Garner, SE
    Fidan, DD
    Frankish, R
    Maxwell, L
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01):
  • [2] Rofecoxib - A review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis
    Matheson, AJ
    Figgitt, DP
    DRUGS, 2001, 61 (06) : 833 - 865
  • [3] Rofecoxib for the treatment of pain
    James M. Scheiman
    Current Treatment Options in Gastroenterology, 1999, 2 (4) : 259 - 262
  • [4] Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone
    Weaver, AL
    Messner, RP
    Storms, WW
    Polis, AB
    Najarian, DK
    Petruschke, RA
    Geba, GP
    Tershakovec, AM
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2006, 12 (01) : 17 - 25
  • [5] Prevalence of patients with low intensity pain symptom severity states during treatment with rofecoxib and ibuprofen for osteoarthritis
    Bellamy, N
    Krupa, D
    Markind, JE
    Reicin, AS
    Malmstrom, K
    OSTEOARTHRITIS AND CARTILAGE, 2004, 12 : S69 - S69
  • [6] Primary analgesic action of acetaminophen and rofecoxib in osteoarthritis
    Shen, H
    Sprott, H
    Aeschlimann, A
    Gay, R
    Uebelhart, D
    Michel, BA
    Gay, S
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 258 - 258
  • [7] The response of knee osteoarthritis patients to treatment with rofecoxib and physiotherapy
    Korzh, IV
    Fedotova, IF
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 357 - 357
  • [8] A comparison of rofecoxib to celecoxib and acetaminophen in the treatment of osteoarthritis.
    Geba, GP
    Weaver, AL
    Schnitzer, TJ
    Fleischmann, RM
    Polis, AB
    Marzura-Wolfe, DM
    Dixon, ME
    Gormley, GJ
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S384 - S384
  • [9] Benefit-risk assessment of rofecoxib in the treatment of osteoarthritis
    Schmidt, H
    Woodcock, BG
    Geisslinger, G
    DRUG SAFETY, 2004, 27 (03) : 185 - 196
  • [10] Benefit-Risk Assessment of Rofecoxib in the Treatment of Osteoarthritis
    Helmut Schmidt
    Barry G. Woodcock
    Gerd Geisslinger
    Drug Safety, 2004, 27 : 185 - 196
12345